The application of current diagnostic protocols of patients with colon cancerin preparation for therapy

Acta Informatica Medica

Volumn 20, Issue 4, 2012, Pages 238-241

  Vukobrat Bijedic, Zora ^a   Husic Selimovic, Azra ^a   Sofic, Amela ^a   Bijedic, Nina ^b   Gogov, Bisera ^a   Djuran, Aleksandra ^a   Redzepovic, Amila ^a   Saray, Aida ^a   Bjelogrlic, Ivana ^c  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b Dzemal Bijedi University of Mostar   (Bosnia and Herzegovina)

^c University of Sarajevo ^*  (Bosnia and Herzegovina)

Author keywords

Colon cancer; Diagnostic protocols

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER THERAPY; COLON ADENOCARCINOMA; COLON BIOPSY; COLON CANCER; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 84873446314     PISSN: 03538109     EISSN: 19865988     Source Type: Journal    
DOI: 10.5455/aim.2012.20.238-241     Document Type: Article

References (10)

1. Ochiai H, Ohishi T, Osumu K, Tokuyama J, Urakami H, Seki S, Shimada A, Matsui A, Isobe Y, Murata Y, Endo T, Ishii Y, Hasegawa H, Matsumoto S, Kitagawa Y. Reevaluation of serum p53 antibody as a marker in colorectal cancer patients. Surg Tuday. 2012; 42(2): 164-168.
2. Tagi T, Matsui T, Kikuchi S, Hoshi S, Ochiai T, Kokuba Y, Kinoshita-Ida Y, Kisumi-Hayashi E, Morimoto K, Imai T, Imoto I, Inazawa J, Otsuji E. Dermokine as a novel biomarker for earlystage coloreectal cancer. J Gastroenterol. 2010; 45(12): 1201-1211.
3. Nozoe T, Rikimaru T, Mori E, Okuyama T, Takahashi I. Increase in both CEA and Ca 19-9 in sera as an independen t prognostic indicator in colorectal carcinoma. J Surg Oncol. 2006; 94 (2): 132-137.
4. Berrospi F, Celis J, Ruiz E, Payet E. En block pancreaticoduodenectomy for right colon cancer inading adjacent organs. J Surg Oncol. 2002; 79: 194-197.
5. Saiura A, Yamamotoo J, Ueno M, Koga R, Seki M, Kokudo N. Long -term survival in patients with localy advanced colon cancer aft er en block pancreaticoduodenectomy and colectomy. Dis. Colon rectum. 2008; 51: 1545-1551.
6. Eldar S, Kemeny MM, Terz JJ. Extended resections for carcinoma of the colon and rectum. Surg Gynecol Obstet. 1985; 161: 319-322.
7. Perez RO, Coser RB, Kiss DR, Iwashita RA, Jukemura J, Cunha JE, Habr-Gama A. Combined resection of the duodenum and the pancreat for localy advanced colon cancer. Curr Surg. 2005; 62: 613-617.
8. Li YH, An X, Xiang XJ, Wang Zq. et al. Clinical signifi cance of a transient increase in carcinoembrionic antigen and carbohydrate antigen 19-9 in patient with metastatic colorectal cancer receiving chemotherapy. Aizeng. 2009; 28 (9): 939-944.
9. Davidson BR, Sams VR, Styles J, Dean C, Boulos PB. Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum. Gut. 1989 Sep; 30(9): 1260-1265.
10. Omranipour R, Doroudian R, Mahmoodzadeh H. Anatomical distribution of colorectal carcinoma in Iran: a retrospective 15-yr study to evaluate rightward shift. Asian Pac J Cancer Prev. 2012; 13(1): 279-282.